| |
| |
|
| Insider
Information: |
Smith Ian F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
267,823 |
|
|
Indirect Shares
|
5,306 |
|
|
| Direct
Value |
$23,264,946 |
|
|
|
Indirect Value
|
$2,550,753 |
|
|
| Total
Shares |
273,129 |
|
|
| Total
Value |
$25,815,699 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
|
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
128 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-05-13 |
4 |
AS |
$26.99 |
$155,442 |
D/D |
(5,730) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-05-20 |
4 |
AS |
$27.47 |
$25,691 |
D/D |
(930) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-07-09 |
4 |
AS |
$35.00 |
$2,850,260 |
D/D |
(81,436) |
84,301 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-11-18 |
4 |
AS |
$26.18 |
$419 |
D/D |
(16) |
84,301 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
|
– • – |
2023-10-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,569 |
84,378 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-23 |
4 |
OE |
$15.60 |
$415,593 |
D/D |
26,432 |
84,631 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-07-24 |
4 |
OE |
$15.60 |
$60,026 |
D/D |
3,820 |
84,830 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-10-23 |
4 |
OE |
$15.60 |
$60,026 |
D/D |
3,820 |
84,830 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-03-22 |
4 |
OE |
$15.60 |
$177,815 |
D/D |
11,308 |
87,096 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-02-22 |
4 |
OE |
$15.60 |
$177,784 |
D/D |
11,306 |
88,534 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2008-02-07 |
4 |
A |
$0.01 |
$97 |
D/D |
9,667 |
90,031 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-02-05 |
4 |
A |
$0.01 |
$121 |
D/D |
12,084 |
93,535 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2009-02-06 |
4 |
AS |
$35.00 |
$1,442,420 |
D/D |
(41,212) |
93,535 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
• – – |
2018-04-26 |
4 |
OE |
$96.87 |
$5,771,989 |
D/D |
53,125 |
99,824 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
|
– • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,570 |
99,948 |
0 |
- |
|
| SLDB |
Solid Biosciences Inc |
|
– • – |
2024-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,256 |
103,207 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2015-10-30 |
4 |
AS |
$124.95 |
$1,302,727 |
D/D |
(10,350) |
107,784 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2007-01-24 |
4 |
A |
$0.01 |
$321 |
D/D |
32,084 |
112,614 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2016-02-03 |
4 |
AS |
$89.90 |
$1,097,691 |
D/D |
(12,084) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2016-05-16 |
4 |
AS |
$82.06 |
$16,576 |
D/D |
(202) |
112,999 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2014-12-12 |
4 |
AS |
$119.82 |
$725,738 |
D/D |
(6,042) |
113,826 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-21 |
4 |
AS |
$157.56 |
$1,663,413 |
D/D |
(10,350) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-07-31 |
4 |
AS |
$152.24 |
$324,865 |
D/D |
(2,125) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-08-02 |
4 |
AS |
$152.49 |
$332,236 |
D/D |
(2,155) |
115,888 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CFO & COO |
• – – |
2017-08-07 |
4 |
AS |
$154.09 |
$660,415 |
D/D |
(4,250) |
115,888 |
0 |
- |
|
128 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
